Schall Thomas J. 4
4 · Immuneering Corp · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Schall Thomas J.
Director
Transactions
- Award
Stock Option
2024-03-11+35,000→ 35,000 totalExercise: $5.93Exp: 2034-03-11→ Class A Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a three year period commencing on April 11, 2024, and will be fully vested and exercisable on March 11, 2027.